Institution profile

松山協和病院

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 03F2603003 +1

Location

Prefecture
Ehime
Address
松山市立花5-1-53

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • がん免疫細胞療法審査委員会

Public score

26.2/ 100

A · Review level
10.0 / 30
B · Technologies
12.6 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1716of 1736

Registered technologies
2
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 26.2
Public score →100

Registered technologies (2)

NK and immune cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
悪性新生物に対するANK細胞(Amplified Natural Killer細胞)自家を用いる、ANK自己リンパ球免疫療法(ANK療法)NK and immune cellsClass III
悪性新生物に対するCTL細胞(Cytotoxic T -Lymphocyte細胞)自家を用いる、CTL療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • がん免疫細胞療法審査委員会

Public document number

  • 03F2603003
  • 03F2603004
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
悪性新生物に対するCTL細胞(Cytotoxic T -Lymphocyte細胞)自家を用いる、CTL療法Class IIIがん免疫細胞療法審査委員会03F2603003
悪性新生物に対するANK細胞(Amplified Natural Killer細胞)自家を用いる、ANK自己リンパ球免疫療法(ANK療法)Class IIIがん免疫細胞療法審査委員会03F2603004

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor